Elsevier

Biochimie

Volume 178, November 2020, Pages 56-68
Biochimie

Cancer diets for cancer patients: Lessons from mouse studies and new insights from the study of fatty acid metabolism in tumors

https://doi.org/10.1016/j.biochi.2020.08.020Get rights and content

Abstract

Specific diets for cancer patients have the potential to offer an adjuvant modality to conventional anticancer therapy. If the concept of starving cancer cells from nutrients to inhibit tumor growth is quite simple, the translation into the clinics is not straightforward. Several diets have been described including the Calorie-restricted diet based on a reduction in carbohydrate intake and the Ketogenic diet wherein the low carbohydrate content is compensated by a high fat intake. As for other diets that deviate from normal composition only by one or two amino acids, these diets most often revealed a reduction in tumor growth in mice, in particular when associated with chemo- or radiotherapy. By contrast, in cancer patients, the interest of these diets is almost exclusively supported by case reports precluding any conclusions on their real capacity to influence disease outcome. In parallel, the field of tumor lipid metabolism has emerged in the last decade offering a better understanding of how fatty acids are captured, synthesized or stored as lipid droplets in cancers. Fatty acids participate to cancer cell survival in the hypoxic and acidic tumor microenvironment and also support proliferation and invasiveness. Interestingly, while such addiction for fatty acids may account for cancer progression associated with high fat diet, it could also represent an Achilles heel for tumors. In particular n-3 polyunsaturated fatty acids represent a class of lipids that can exert potent cytotoxic effects in tumors and therefore represent an attractive diet supplementation to improve cancer patient outcomes.

Introduction

Today, cancer is still the second leading cause of death worldwide despite the fact that 30–50% of cancers are preventable according to the World Health Organization. In 2018, the World Cancer Research Fund/American Institute for Cancer Research listed food habit recommendations among the factors decreasing the risk of cancer development. Human diet should be mainly composed of whole grains, vegetables, fruits and beans instead of red meat and ultra-processed foods rich in fat, starch and sugars. Alcoholic beverages and sugar-sweetened drinks are also to be avoided [1,2]. The well-known traditional Mediterranean diet appears to fit within these recommendations. Indeed, eating habits of populations bordering the Mediterranean Sea have received a lot of attention during the past decades for their health benefits. This diet is characterized by a generous intake of whole grains, nuts, seeds, vegetables and fruits. Fish is preferred to processed meat and olive oil is the major source of fat. The favorable health effects on cancer prevention are associated with the presence of short-chain fatty acids, antioxidants and omega-3 (n-3) polyunsaturated fatty acids (PUFAs) [3,4]. Lately, a northern substitute to the Mediterranean diet, the Nordic diet, has also come under scrutiny [5]. Its composition, although very similar, is characterized by the presence of rapeseed oil rather than olive oil. Both oils have roughly the same amounts of monounsaturated fatty acids (MUFAs) but rapeseed oil contains less saturated fatty acids (SFAs) and more PUFAs [6]. The two diets are considered as healthy regional diets and offer similar protective effects against cancer [7].

Although not all studies are totally convincing, there is an extensive literature highlighting the strong link between diet and cancer prevention [[8], [9], [10]]. One area that is less studied but is attracting more and more attention is the effect of diet on cancer treatment with or without additional therapies, which will be detailed in this review.

Section snippets

Diet composition

Diet integration in the reflection about optimizing cancer patient care is essential. The most obvious rationale comes from the needs for proliferating cancer cells to meet their biosynthetic and bioenergetic requirements. Those may require particular nutrients or larger amounts of regular nutrients when compared with the metabolic needs of healthy cells, even when from the same origin as cancer cells [11]. These specific demands can actually be exploited in order to target cancer cells that

Carbohydrate-restricted diets

Carbohydrate intake was the first to be altered in diets dedicated for cancer patients. It is indeed known since the beginning of the 20th century that cancer cells consume tremendous amounts of glucose and release lactate. Stimulated glycolysis in tumors was even reported to occur in the presence of oxygen by Otto Warburg who thought that mitochondria were dysfunctional in cancer cells [15]. We know today that besides a few exceptions where tricarboxylic acid cycle (TCA) enzymes are mutated,

Protein-targeted diets

Another way to take advantage of cancer metabolism abnormalities is to target some specific amino acids. Indeed, as some amino acids are engaged in metabolic pathways supporting key biosynthetic processes, amino acid-targeted diets could also be relevant in the fight against cancer. The most studied residues, the starvation of which is associated with tumor growth inhibitory effects, are essential amino acids including leucine, lysine and methionine, and non-essential ones including serine,

Fatty acid-orientated diets

Long underestimated, the importance of lipid metabolism in tumor growth is nowadays well accepted. Many recent reviews have highlighted the relevance of targeting lipid metabolism in cancer therapies [[79], [80], [81], [82], [83], [84]]. The term lipid is used to cover a very large family that encompasses a multitude of categories such as fatty acyls, glycerolipids, glycerophospholipids, sphingolipids and sterols [85]. Here below, we will focus on specific issues mainly related to the sources

Concluding remarks

The purpose of this review was to survey the evidence that support how nutrition may interfere with cancer progression, in particular because of the intimate link between metabolism and cancer cell growth and invasiveness. The establishment of a particular diet that would help reducing tumor growth per se or act as an adjuvant to standard therapies appears very attractive. Whether imbalanced diets such as CR or KD, or supplementation of normal diet with n-3 PUFA or a combination of both

Funding

This work was supported by grants from the Fonds de la Recherche Scientifique (F.R.S.-FNRS), the Télévie, the Belgian Foundation against cancer, the J. Maisin Foundation, the Fondation Louvain and an Action de Recherche Concertée (ARC 19/24-096).

References (187)

  • B.G. Allen et al.

    Ketogenic diets as an adjuvant cancer therapy: history and potential mechanism

    Redox Biol.

    (2014)
  • E. Cellarier et al.

    Methionine dependency and cancer treatment

    Canc. Treat Rev.

    (2003)
  • S. Chaturvedi et al.

    Exploiting methionine restriction for cancer treatment

    Biochem. Pharmacol.

    (2018)
  • M.T. Snaebjornsson et al.

    Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer

    Cell Metabol.

    (2020)
  • Q. Liu et al.

    Targeting lipid metabolism of cancer cells: a promising therapeutic strategy for cancer

    Canc. Lett.

    (2017)
  • M. Amiri et al.

    Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers

    Gene

    (2018)
  • B. Peck et al.

    Lipid metabolism at the nexus of diet and tumor microenvironment

    Trends Canc.

    (2019)
  • Q. Zhou et al.

    Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1

    J. Biol. Chem.

    (2000)
  • I. Zhang et al.

    Pharmacological inhibition of lipid droplet formation enhances the effectiveness of curcumin in glioblastoma

    Eur. J. Pharm. Biopharm.

    (2016)
  • Cancer World Research Fund/American Institute for Cancer Research

    Recommendations and Public Health and Policy Implications

    (2018)
  • World Health Organization, Health Topics : cancer,...
  • M.G. Donovan et al.

    Mediterranean diet: prevention of colorectal cancer

    Front. Nutr.

    (2017)
  • A. Giacosa et al.

    Cancer prevention in Europe: the Mediterranean diet as a protective choice

    Eur. J. Canc. Prev.

    (2013)
  • E. Bere et al.

    Towards health-promoting and environmentally friendly regional diets a Nordic example

    Publ. Health Nutr.

    (2009)
  • C. Kyro et al.

    Adherence to a healthy Nordic food index is associated with a lower incidence of colorectal cancer in women: the Diet, Cancer and Health cohort study

    Br. J. Nutr.

    (2013)
  • T.J. Key et al.

    Nutrition and the prevention of cancer

    J. Fam. Health Care

    (2006)
  • M.L. McCullough et al.

    Diet and cancer prevention

    Oncogene

    (2004)
  • P. Greenwald et al.

    Diet and cancer prevention: an overview

    Semin. Oncol.

    (1983)
  • M. Keenan et al.

    Alternative fuels for cancer cells

    Canc. J.

    (2015)
  • Washington State University

    Nutrition basics

  • Conseil Supérieur de la Santé

    Recommandations alimentaires pour la population belge adulte

    (2019)
  • E.C. Lien et al.

    A framework for examining how diet impacts tumour metabolism

    Nat. Rev. Canc.

    (2019)
  • J. Maroon et al.

    Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme

    J. Child Neurol.

    (2013)
  • D. Kritchevsky

    Caloric restriction and cancer

    J. Nutr. Sci. Vitaminol.

    (2001)
  • M. Lv et al.

    Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis

    PLoS One

    (2014)
  • M.S. de Lorenzo et al.

    Caloric restriction reduces growth of mammary tumors and metastases

    Carcinogenesis

    (2011)
  • S. Lanza-Jacoby et al.

    Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1/Cre mouse model of pancreatic cancer

    Exp. Biol. Med.

    (2013)
  • C. Galet et al.

    Effects of calorie restriction and IGF-1 receptor blockade on the progression of 22Rv1 prostate cancer xenografts

    Int. J. Mol. Sci.

    (2013)
  • P. Mukherjee et al.

    Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model

    Br. J. Canc.

    (2002)
  • L.M. Nogueira et al.

    Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1

    Cancer Med.

    (2012)
  • N.Y. Kalaany et al.

    Tumours with PI3K activation are resistant to dietary restriction

    Physiol. Behav.

    (2017)
  • L. Bordone et al.

    SIRT1 transgenic mice show phenotypes resembling calorie restriction

    Aging Cell

    (2007)
  • D. Herranz et al.

    Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer

    Nat. Commun.

    (2010)
  • D.D. Weber et al.
    (2015)
  • C.E. Champ et al.

    Oncologist nutrient restriction and radiation therapy for cancer Treatment : when less is more

    Oncol.

    (2013)
  • C. Lee et al.
    (2012)
  • F.M. Safdie et al.

    Fasting and cancer treatment in humans: a case series report

    Aging

    (2009)
  • L. Raffaghello et al.

    Fasting and differential chemotherapy protection in patients

    Cell Cycle

    (2010)
  • M. Kj et al.

    Ketogenic diets for drug-resistant epilepsy ( Review )

    Cochrane Database Syst. Rev.

    (2018)
  • D. Huang et al.

    Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress

    Cell Res.

    (2016)
  • Cited by (13)

    • Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster

      2022, Cytokine
      Citation Excerpt :

      Downregulation of the enzyme that catalyses this reaction, acetyl-CoA synthetase 2 (ACSS2), is associated with aggressive colorectal cancer [143]. ACC2 converts acetyl-CoA to malonyl-CoA, which, ultimately produce a saturated 16-C palmitate [144]. This functions as the precursor of long chain nonessential FAs and 18-C oleic acid via the reactions catalysed by the endoplasmic reticular enzymes elongases and desaturases [145].

    • Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects

      2021, Cell Metabolism
      Citation Excerpt :

      Most of these dietary studies are based on the original idea that reducing tumor supply of major nutrients could limit cancer cell proliferation. Calorie restriction most often through a low carbohydrate content and more recently diets excluding specific amino acids have been investigated (Dierge et al., 2020; Lv et al., 2014). Applications of these approaches in cancer patients, including via the ketogenic diet that makes fat-generating ketone bodies to spare healthy organs, face obvious issues including weight loss, associated fatigue, and weakness together with practical difficulties in implementing these diets in an everyday cancer patient’s life (Dierge and Feron, 2019; Nestle, 2018).

    • The Antitumor Effects of α-Linolenic Acid

      2024, Journal of Personalized Medicine
    View all citing articles on Scopus

    Each author actively participated to the conception of the work, the collection and analysis of the data and the writing of the manuscript. They all have approved the final article.

    View full text